The FDA has ordered a recall of Medtronic’s SynchroMed II implantable infusion pump, models 8637-20 and 8637-40, distributed between May 2004 and July 8, 2011, according to an FDA news release. The ...

Much of Medtronic’s work in diabetes this year has focused specifically on bringing new technologies to European patients—and its latest purchase continues this trend. The medtech giant snapped up the ...

DUBLIN, July 07, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today introduced the MiniMed™ Mio™ Advance infusion set to all Medtronic insulin pump ...

September 13, 2011 — A class I recall has been issued for certain Medtronic implantable programmable infusion pumps (SynchroMed II), the US Food and Drug Administration (FDA) announced yesterday.

The thin plastic tubing of infusion sets that connect insulin pumps to the body typically need to be changed every two or three days—but a new version in the U.S. more than doubles that timespan. The ...

Medtronic, Inc., said Wednesday that eight deaths and 270 serious or life-threatening injuries that occurred between May 1996 and September 2010 were tied to an improperly working product that it ...

DUBLIN, June 13, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced data on its extended wear infusion set presented at the virtual 80th ...

Medtronic has issued an urgent medical device correction on its SynchroMed II implantable drug infusion pumps, warning that the batteries in certain devices might suddenly fail, according to a news ...

TOLOCHENAZ, SWITZERLAND - Medtronic, Inc. today announced the European launch of MiniMed® Duo(TM), the world's first two-in-one breakthrough that combines a glucose sensor and insulin infusion set ...

Late last week, medical device giant Medtronic received FDA approval for its MiniMed 780G system. The device is an insulin pump that automatically adjusts and corrects type 1 diabetes patients’ ...

Add Yahoo as a preferred source to see more of our stories on Google. Pamela, a 64-year-old from Arkansas, began using an insulin pump to manage her type 2 diabetes in 2013. She and her husband, Gary, ...